09252014settlement
408 Views

Carlyle LPs to share in collusion suit settlement costs: Buyouts

The Carlyle Group’s $115 million settlement of a lawsuit that alleged it colluded with other buyout shops to depress deal prices will be paid through a combination of Carlyle Partners IV fund capital, insurance, balance sheet capital, and contributions from some employees of the firm.

VC-backed Kite Pharma unveils IPO

Kite Pharma has launched its IPO after pricing its 7.5 million shares at $17 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “KITE.” Jefferies, Credit Suisse Securities (USA) and Cowen and Company are the lead underwriters. Based in Santa Monica, Calif., Kite Pharma is a biopharmaceutical firm focused on treating cancer. Kite Pharma’s backers include Alta Partners and TPG Capital.

PEHUB Community

Join the 12506 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget